NCT02297386View on ClinicalTrials.gov

[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Prostate CancerLocalized Prostate Cancer
Interventions
DRUG

[18F] DIHYDRO-TESTOSTERONE

DEVICE

PET scan

DEVICE

MRI

OTHER

Blood draw

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02297386 - [18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer | Biotech Hunter | Biotech Hunter